Aigen Investment Management, LP Vir Biotechnology, Inc. Transaction History

Aigen Investment Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$7.63 - $12.66 $146,679 - $243,375	19,224 New	19,224 $171,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $177,562 - $478,292	19,427 New	19,427 $182,000
Q1 2022 May 05, 2022	SELL	$21.19 - $40.01 $194,397 - $367,051	-9,174 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$30.97 - $54.03 $284,118 - $495,671	9,174 New	9,174 $418,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.